Targeted Protein Degraders: Trends, Challenges, and Solutions
Since 2016, WuXi AppTec has built a comprehensive discovery platform focused on Targeted Protein Degraders (TPDs). Our platform enables research teams to investigate the complete TPD functional cycle, from binary and ternary complex formation to protein ubiquitination and degradation. Our end-to-end services encompass over 20 assay technologies, 10+ types of TPD molecules, and one-stop screening for proteins of interest (POI) and linkers using a bifunctional DNA-encoded library.
Our seamless partnership with WuXi Chemistry enables us to deliver all-encompassing solutions that leverage chemistry, structural biology, target validation, in vitro pharmacology, in vivo evaluation, and biomarker analysis.
Related Content
Targeted protein degradation (TPD) approaches, including molecular glue degraders (MGDs) and proteolysis targeting chimeras (PROTACs), can overcome traditional occupancy-based inhibitor...
VIEW RESOURCEDespite major advances in small molecule drug development, most disease-relevant proteins remain beyond the reach of conventional therapeutics. Molecular glues...
VIEW RESOURCE
